Pfizer Japan Obtains Manufacturing Approval of Gabapentin for Antiepileptic.Tokyo, Japan, Aug 4, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Pfizer Japan Inc. has obtained manufacturing approval of Gabapentin on July 26. Gabapentin can be taken in conjunction with other drugs. Since it does not induce in·duce v. 1. To bring about or stimulate the occurrence of something, such as labor. 2. To initiate or increase the production of an enzyme or other protein at the level of genetic transcription. 3. drug-metabolizing enzymes, it has proven to be safely taken with other drugs. Gabapentin is known by product name Neurontin abroad, and is distributed in 91 countries worldwide. 70% of the patients in Japan can control their disease by taking the conventional drug; however 30% suffers from intractable intractable /in·trac·ta·ble/ (in-trak´tah-b'l) resistant to cure, relief, or control. in·trac·ta·ble adj. 1. Difficult to manage or govern; stubborn. 2. epilepsy epilepsy, a chronic disorder of cerebral function characterized by periodic convulsive seizures. There are many conditions that have epileptic seizures. Sudden discharge of excess electrical activity, which can be either generalized (involving many areas of cells in that requires multiple drug treatments. It is expected that the launch of Gabapentin in Japan will improve the quality of life for these patients. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion